Therapeutic Expertise
State-of-the-art technologies
Deep clinical and regulatory expertise
Focused on diabetes, NASH and obesity
Therapeutic Expertise


Connecting scientific expertise, metabolic focus and advanced methodologies with full scope CRO services to generate highly conclusive study data and support the decision making milestones of our clients.


ProSciento is at the forefront of global drug and device development for diabetes and diabetes-related complications and disorders. Our long-standing commitment to innovation has yielded a unique portfolio of therapeutically focused services, clinical research methods and capabilities to enable effective, comprehensive, and highly informative evaluation of investigational diabetes drugs.

Learn more about ProSciento’s unparalleled expertise and experience in diabetes... READ MORE »

NASH (Nonalcoholic Steatohepatitis)

ProSciento is a leading service provider in NASH (Nonalcoholic Steatohepatitis) clinical research and development, complemented by our deep experience and expertise in diabetes and obesity. We offer an integrated portfolio of today’s most advanced imaging techniques and circulating biomarkers to support the development of drug candidates for NASH and NAFLD.

Learn more about ProSciento’s state-of-the-art biomarker and imaging methods to address NASH and NAFLD... READ MORE »


The team at ProSciento has decades of experience in obesity drug development, including research, clinical trial design, clinical development and regulatory strategy and interactions. The company employs advanced methodologies to assess body composition, body fat distribution, food intake, energy metabolism and adipose tissue function, as well as innovative study design strategies to address the complexities of subject recruitment and retention for weight-loss trials.

Learn more about ProSciento’s long-standing expertise in obesity... READ MORE »

Stay Connected

Would you like to receive updates from ProSciento?

I'm interested in receiving: